CHSU Discovery

6 results in Articles
  1. Ibarra F., Bae R., Haghighat B. The Annals of pharmacotherapy 2025

    OBJECTIVESummarize the studies evaluating the use of subcutaneous (SQ) insulin in the management of diabetic ketoacidosis (DKA) in adults and pediatrics.DATA SOURCESA PubMed literature search was conducted for articles published between 2000 and the…

  2. Wang Y., Grainger D.W. Frontiers in Drug Delivery

    Nearly a half-century after original liposome discovery as a prospective lipid pharmaceutical carrier, the global liposomal drug delivery market has increased dramatically, with an annual market growth rate of 13.2%, valued at ∼$6,993 million …

  3. Eid T.J., Kalkat B., Shah S.A. Journal of pharmacy practice 2015
  4. Gupta D., Kumar A., Mandloi A., Shenoy V. Pharmacological research 2021

    Pulmonary fibrosis is a devastating lung disease with multifactorial etiology characterized by alveolar injury, fibroblast proliferation and excessive deposition of extracellular matrix proteins, which progressively results in respiratory failure an…

  5. Shenoy A.K., Lu J. Molecular & cellular oncology 2017

    The relevance of epithelial-to-mesenchymal transition (EMT) in cancer is still under debate. Recently, we reported that EMT bestows key pericyte properties on cancer cells and may thus represent epithelial-to-pericyte transition (EPT). Carcinoma cel…

  6. Huang J.X.F., Yousaf A., Moon J., Ahmed R., Uppal K., Pemminati S. Cureus 2025

    Dyslipidemia refers to abnormal levels of lipids in the bloodstream, typically exhibiting an increased pattern. Total cholesterol, high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), and triglycerides (TGs) are…

Loading...